22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes

Core Viewpoint - The FDA's proposal to mandate reduced nicotine content in cigarettes has cleared the OMB review, which could significantly impact public health by reducing smoking-related harms [1][2]. Group 1: FDA Proposal and Company Position - The FDA's proposed tobacco product standard aims for a drastic reduction in nicotine levels in cigarettes, aligning with public health goals and the mission of 22nd Century Group [1][2]. - 22nd Century Group supports the FDA's initiative and emphasizes its role in research and development of reduced nicotine products, including the VLN brand [2][3]. Group 2: Product and Market Strategy - The VLN cigarette contains 95% less nicotine than traditional cigarettes, providing smokers with a familiar alternative that helps control nicotine consumption [3]. - The company plans to expand its product line with additional reduced nicotine content products and increase consumer awareness of low nicotine cigarettes as a distinct market category [2][3]. Group 3: Company Overview - 22nd Century Group is a pioneering company in nicotine harm reduction, with a manufacturing facility in Mocksville, North Carolina, capable of producing over 45 million cartons of tobacco products annually [3]. - The company holds a comprehensive patent portfolio that ensures it is the only provider of low nicotine combustible cigarettes in the U.S. and key international markets [3].